Home / News / India News / Article /
Brazil scraps Covaxin's EUA application after Bharat Biotech terminates pact with partners
Updated On: 27 July, 2021 11:30 AM IST | Hyderabad | PTI
Earlier Anvisahad suspended the clinical studies of Bharat Biotechs COVID-19 vaccine Covaxin in Brazil following the termination of the companys agreement with its partners there
This picture has been used for representational purpose
After suspending the proposed clinical trials of Bharat Bioetchs COVID-19 vaccine Covaxin, Brazil has now scrapped the Emergency Use Authorisation request made by the Indian company for the jab.
The Brazilian health regulator's decision comes after the vaccine maker informed the South American country about the termination of its pact with its partners in that country.
How do you like the new new mid-day.com experience? Share your feedback and help us improve.
Trending Stories
Latest Photos
Latest Videos
Latest Web Stories
ADVERTISEMENT
Mid-Day Fast
ADVERTISEMENT
ADVERTISEMENT